Skip to main content

Advertisement

Log in

Comparative Characteristics of Patients with Type 2 Diabetes Mellitus Treated by Bariatric Surgery Versus Medical Treatment: a Multicentre Analysis of 277,862 Patients from the German/Austrian DPV Database

  • Original Contributions
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

Introduction

Bariatric surgery is a well-established treatment option for serious obesity and concomitant type 2 diabetes mellitus (T2DM). In this analysis, we investigated predictors for bariatric surgery in everyday clinical practice.

Materials and Methods

In the DPV-registry, patients with T2DM from Germany and Austria treated by bariatric surgery were compared to non-surgery controls by descriptive statistics and regression analysis.

Results

Among 277,862 patients with T2DM, 0.07% underwent bariatric surgery. Surgery patients were predominantly female [61.20%], younger [median age (Q1;Q3) 54.74(47.40;61.61) vs. 70.04 (60.36;77.58) years] and had a longer diabetes duration [11.21 (7.15;17.93) vs. 8.36 (2.94;14.91) years]. They had a higher BMI [40.02 vs. 30.61 kg/m2, adjusted p < 0.0001] and a slightly lower HbA1c [7.25 vs. 7.56%, adjusted p < 0.05]. There was a trend using more often insulin therapy (52.79 vs.50.08%, n.s.) with no difference in insulin dose/kg × day [0.56 vs. 0.58, n.s.]. Sleeve gastrectomy was performed most frequently, followed by Roux-en-Y gastric bypass, gastric banding, gastric balloon and others. A 2-year follow-up data in 29 patients demonstrated significant reductions in BMI [45.23 to 38.00 kg/m2, p < 0.005] and HbA1c [7.98 to 6.98%, p < 0.005], and a trend for reduced insulin requirements [62.07 vs. 44.83%, n.s.].

Conclusion

Despite favourable 2-year outcomes, bariatric surgery is still used rarely in patients with T2DM and obesity. BMI rather than metabolic control seems to represent the major selector for or against bariatric surgery in T2DM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. World Health Organization. Diabetes: Fact Sheet. June 2016. http://www.who.int/mediacentre/factsheets/fs312/en/.

  2. Whiting DR, Guariguata L, Weil C, et al. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94(3):311–21.

    Article  PubMed  Google Scholar 

  3. World Health Organization. Obesity and overweight: fact sheet 310. June 2016. http://www.who.int/mediacentre/factsheets/fs311/en/.

  4. Seshasai SR et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011;364(9):829–41.

    Article  CAS  Google Scholar 

  5. Piepoli MF, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the European Society of Cardiology and Other Societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 10 societies and by invited experts): developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016.

  6. Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004;291(3):335–42.

    Article  CAS  PubMed  Google Scholar 

  7. Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery worldwide 2013. Obes Surg. 2015;25(10):1822–32.

    Article  CAS  PubMed  Google Scholar 

  8. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292(14):1724–37.

    Article  CAS  PubMed  Google Scholar 

  9. Garvey WT, Mechanick JI, Brett EM, et al. American Association of Clinical Endocrinologists and AMERICAN College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity executive summary complete guidelines available at https://www.aace.com/publications/guidelines. Endocr Pract. 2016;22(7):842–84.

    Article  PubMed  Google Scholar 

  10. Adams TD, Davidson LE, Litwin SE, et al. Health benefits of gastric bypass surgery after 6 years. JAMA. 2012;308(11):1122–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Brethauer SA et al. Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus. Ann Surg. 2013;258(4):628–36. discussion 636–7

    PubMed  PubMed Central  Google Scholar 

  12. Ikramuddin S, Korner J, Lee WJ, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. JAMA. 2013;309(21):2240–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Kashyap SR, Bhatt DL, Wolski K, et al. Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatment. Diabetes Care. 2013;36(8):2175–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Mingrone G, Panunzi S, de Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366(17):1577–85.

    Article  CAS  PubMed  Google Scholar 

  15. Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes—3-year outcomes. N Engl J Med. 2014;370(21):2002–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Sjostrom L et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357(8):741–52.

    Article  PubMed  Google Scholar 

  17. Muller-Stich BP et al. Surgical versus medical treatment of type 2 diabetes mellitus in nonseverely obese patients: a systematic review and meta-analysis. Ann Surg. 2015;261(3):421–9.

    Article  PubMed  Google Scholar 

  18. Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366(17):1567–76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Baskota A, Li S, Dhakal N, et al. Bariatric surgery for type 2 diabetes mellitus in patients with BMI <30 kg/m2: a systematic review and meta-analysis. PLoS One. 2015;10(7):e0132335.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Rubino F, Nathan DM, Eckel RH, et al. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Diabetes Care. 2016;39(6):861–77.

    Article  CAS  PubMed  Google Scholar 

  21. Grabert M, Schweiggert F, Holl RW. A framework for diabetes documentation and quality management in Germany: 10 years of experience with DPV. Comput Methods Prog Biomed. 2002;69(2):115–21.

    Article  Google Scholar 

  22. Hecker W, Grabert M, Holl RW. Quality of paediatric IDDM care in Germany: a multicentre analysis. German Paediatric Diabetology Group. J Pediatr Endocrinol Metab. 1999;12(1):31–8.

    Article  CAS  PubMed  Google Scholar 

  23. Carlsson LM et al. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med. 2012;367(8):695–704.

    Article  CAS  PubMed  Google Scholar 

  24. Stroh C, Birk D, Flade-Kuthe R, et al. Status of bariatric surgery in Germany—results of the nationwide survey on bariatric surgery 2005–2007. Obes Facts. 2009;2(Suppl 1):2–7.

    Article  PubMed  Google Scholar 

  25. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(3):248–56. e5

    Article  PubMed  Google Scholar 

  26. Cummings DE, Cohen RV. Bariatric/metabolic surgery to treat type 2 diabetes in patients with a BMI <35 kg/m2. Diabetes Care. 2016;39(6):924–33.

    Article  PubMed  PubMed Central  Google Scholar 

  27. De Paula AL et al. Prospective randomized controlled trial comparing 2 versions of laparoscopic ileal interposition associated with sleeve gastrectomy for patients with type 2 diabetes with BMI 21-34 kg/m(2). Surg Obes Relat Dis. 2010;6(3):296–304.

    Article  PubMed  Google Scholar 

  28. Robert-Koch-Institut, Prävalenz von Diabetesmellitus. Faktenblatt zu DEGS1: Studie zur GesundheitErwachsener in Deutschland (2008–2011). RKI, Berlin. www.degs-studie.de, 2016.

  29. Yska JP, van Roon EN, de Boer A, et al. Remission of type 2 diabetes mellitus in patients after different types of bariatric surgery: a population-based cohort study in the United Kingdom. JAMA Surg. 2015;150(12):1126–33.

    Article  PubMed  Google Scholar 

  30. Weiner R, el-Sayes I, Manger T, et al. Antidiabetic efficacy of obesity surgery in Germany: a quality assurance nationwide survey. Surg Obes Relat Dis. 2014;10(2):322–7.

    Article  PubMed  Google Scholar 

  31. Chang SH, Stoll CRT, Song J, et al. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003–2012. JAMA Surg. 2014;149(3):275–87.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Kenngott HG, Clemens G, Gondan M, et al. DiaSurg 2 trial—surgical vs. medical treatment of insulin-dependent type 2 diabetes mellitus in patients with a body mass index between 26 and 35 kg/m2: study protocol of a randomized controlled multicenter trial—DRKS00004550. Trials. 2013;14:183.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We acknowledge the participating diabetes centres in Germany and Austria listed in alphabetical order:

Aachen - Innere RWTH, Aidlingen Praxisgemeinschaft, Altötting-Burghausen Innere Medizin, Asbach Kamillus-Klinik Innere, Augsburg Innere, Zentralklinikum, Bad Aibling Internist. Praxis, Bad Driburg/Bad Hermannsborn Innere, Bad Hersfeld Innere, Bad Kreuznach-St.Marienwörth-Innere, Bad Kreuznach-Viktoriastift, Bad Krozingen Klinik Lazariterhof Park-Klinikum, Bad Lauterberg Diabeteszentrum Innere, Bad Mergentheim - Diabetesfachklinik, Bad Mergentheim - Gemeinschaftspraxis DM-dorf Althausen, Bad Oeynhausen Herz-und Diabeteszentrum NRW, Bad Orb Spessart Klinik Reha, Bad Reichenhall Kreisklinik Innere Med., Bad Säckingen Hochrheinklinik Innere, Bautzen Oberlausitz KK, Bayreuth Innere Medizin, Berchtesgaden CJD, Berchtesgaden MVZ Innere Med, Berlin DRK-Kliniken, Berlin Endokrinologikum, Berlin Evang. Krankenhaus Königin Elisabeth, Berlin Klinik St. Hedwig Innere, Berlin Oskar Zieten Krankenhaus Innere, Berlin Parkklinik Weissensee, Berlin Schlosspark-Klinik Innere, Berlin St. Josephskrankenhaus Innere, Berlin Vivantes Hellersdorf Innere, Bottrop Knappschaftskrankenhaus Innere, Braunfels-Wetzlar Innere, Bremen - Mitte Innere, Castrop-Rauxel Rochus-Hospital, Chemnitz-Hartmannsdorf Innere Medizin - DIAKOMED-1, Coesfeld/Dülmen Innere Med., Darmstadt Innere Medizin, Deggendorf Medizinische Klinik II, Dortmund Knappschaftskrankenhaus Innere, Dortmund Medizinische Kliniken Nord, Dortmund-Hombruch Marienhospital, Dortmund-St. Josefshospital Innere, Dortmund-West Innere, Duisburg Evang. und Johanniter Krhs Innere, Duisburg Malteser Rhein-Ruhr St. Anna Innere, Duisburg Malteser St. Johannes, Duisburg-Huckingen, Duisburg-Huckingen Malteser Rhein-Ruhr ST. Johannes, Duisburg-St.Johannes Helios, Eberswalde Klinikum Barnim Werner Forßmann - Innere, Eisleben Lutherstadt Helios-Klinik, Erlangen Uni Innere Medizin, Essen Diabetes-Schwerpunktpraxis, Eutin St.-Elisabeth Innere, Forchheim Diabeteszentrum SPP, Frankfurt Diabeteszentrum Rhein-Main-Erwachsenendiabetologie (Bürgerhospital), Frankfurt Uni-Klinik Innere, Freiburg Uni Innere, Friedberg Innere Klinik, Fulda Innere Medizin, Gaissach Fachklinik der Deutschen Rentenversicherung Bayern Süd, Geislingen Klinik Helfenstein Innere, Gelnhausen Innere, Gießen Ev. Krankenhaus Mittelhessen, Göppingen Innere Medizin, Güstrow Innere, Halberstadt Innere Med. St. Salvator AMEOS Klinik, Hamburg Endokrinologikum, Hanau St. Vincenz - Innere, Hannover Henriettenstift - Innere, Heidelberg St. Josefskrankenhaus, Heidelberg Uniklinik Innere, Heidenheim Arztpraxis Allgemeinmed, Heilbronn Innere Klinik, Herford Innere Med I, Heringsdorf Inselklinik, Herne Evan. Krankenhaus Innere, Herten St. Elisabeth Innere Medizin, Herzberg Kreiskrankenhaus Innere, Hildesheim GmbH - Innere, Idar Oberstein Innere, Ingolstadt Klinikum Innere, Innsbruck Universitätsklinik Innere, Iserlohn Innere Medizin, Kamen Klinikum Westfalen Hellmig Krankenhaus, Karlsburg Klinik für Diabetes & Stoffwechsel, Kassel Rot-Kreuz-Krankenhaus Innere, Kaufbeuren Innere Medizin, Kempen Heilig Geist - Innere, Kempen Heilig Geist-KHS - Innere, Kirchheim-Nürtingen Innere, Kleve Innere Medizin, Koblenz Kemperhof 1. Med. Klinik, Konstanz Innere Klinik, Krefeld Alexianer Innere, Krefeld Innere Klinik, Krefeld-Uerdingen St. Josef Innere, Kreischa-Zscheckwitz Klinik Bavaria, Landau/Annweiler Innere, Lilienthal Diabeteszentrum, Limburg Innere Medizin, Lindenfels Luisenkrankenhaus Innere, Lindenfels Luisenkrankenhaus Innere 2, Linz AKH - 2. Med, Linz Krankenhaus Barmherzige Schwestern Kardiologie Abt. Int. II, Ludwigsburg Innere Medizin, Ludwigshafen diabetol. SPP, Lübeck Uni-Klinik Innere Medizin, Lünen Klinik am Park, Magdeburg Städtisches Klinikum Innere, Mannheim Uniklinik Innere Medizin, Marburg - UKGM Endokrinologie & Diabetes, Marktredwitz Innere Medizin, Marpingen-SPP, Moers - St. Josefskrankenhaus Innere, Murnau am Staffelsee - diabetol. SPP, Mölln Reha-Klinik Hellbachtal, Mühlacker Enzkreiskliniken Innere, München Diabetes-Zentrum Süd, München Schwerpunktpraxis, Münster Clemens-Hospital Innere, Münster Herz Jesu Innere, Nagold Kreiskrankenhaus Innere, Neumarkt Innere, Neunkirchen Innere Medizin, Neuwied Marienhaus Klinikum St. Elisabeth Innere, Nidda Bad Salzhausen Klinik Rabenstein/Innere-1 Reha, Nidda Bad Salzhausen Klinik Rabenstein/Innere-2 Reha, Oberhausen Innere, Offenbach/Main Innere Medizin, Oldenburg Schwerpunktpraxis, Oschersleben MEDIGREIF Bördekrankenhaus, Osterkappeln Innere, Ottobeuren Kreiskrankenhaus, Pfullendorf Innere Medizin, Pirmasens Städtisches Krankenhaus Innere, Plauen Vogtlandklinikum, Prenzlau Krankenhaus Innere, Rastatt Kreiskrankenhaus Innere, Recklinghausen Dialysezentrum Innere, Reutlingen Klinikum Steinenberg Innere, Rosenheim Innere Medizin, Rosenheim Schwerpunktpraxis, Rostock Universität Innere Medizin, Saaldorf-Surheim Diabetespraxis, Scheidegg Prinzregent Luitpold, Schwerin Innere Medizin, Schwäbisch Hall Diakonie Innere Medizin, Sinsheim Innere, Spaichingen Innere, Stuttgart Bethesda Agaplesion, Sylt Rehaklinik, Tettnang Innere Medizin, Timmendorfer Strand, Traunstein diabetol. Schwerpunktpraxis, Trostberg Innere, Ulm Endokrinologikum, Ulm Schwerpunktpraxis Bahnhofsplatz, Ulm Uni Innere Medizin, Villingen-Schwenningen SPP, Villingen-Schwenningen Schwarzwald-Baar-Klinikum Innere, Wangen Oberschwabenklinik Innere Medizin, Weisswasser Kreiskrankenhaus, Wernberg-Köblitz SPP, Wetzlar Schwerpunkt-Praxis, Wien 3. Med. Hietzing Innere, Wien Rudolfstiftung, Wien SMZ Ost Donauspital, Wien Uni Innere Med III, Wien Wilhelminenspital 5. Med. Abteilung, Wilhelmshaven St. Willehad Innere, Wittenberg Innere Medizin, Wolgast Innere Medizin, Zweibrücken Ev. KH. Innere.

Funding

This work was supported by Kompetenznetz Diabetes Mellitus (Competence Network for Diabetes Mellitus), funded by the Federal Ministry of Education and Research (FKZ 01GI1106), which was integrated into the German Center for Diabetes Research as of January 2015. In addition, the DPV initiative was supported by the European Foundation for the Study of Diabetes (EFSD), the EU-IMI2-initative, DIRECT and the German Diabetes Association (DDG).

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Katharina Laubner.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Disclosure

K. L. has nothing to disclose.

N. P. has nothing to disclose.

J. B. has nothing to disclose.

A. S. has nothing to disclose.

M. A. has nothing to disclose.

R. W. has nothing to disclose.

F.G. has nothing to disclose.

D. K. has nothing to disclose.

E.B. has nothing to disclose.

J. S. has nothing to disclose.

R.W.H. has nothing to disclose.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Laubner, K., Prinz, N., Brückel, J. et al. Comparative Characteristics of Patients with Type 2 Diabetes Mellitus Treated by Bariatric Surgery Versus Medical Treatment: a Multicentre Analysis of 277,862 Patients from the German/Austrian DPV Database. OBES SURG 28, 3366–3373 (2018). https://doi.org/10.1007/s11695-018-3380-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-018-3380-z

Keywords

Navigation